DK130628B - Fremgangsmåde til stabilisering af en opløsning af 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-carbomethoxy-1,4-dihydropyridin til brug i gelatine-bidekapsler. - Google Patents

Fremgangsmåde til stabilisering af en opløsning af 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-carbomethoxy-1,4-dihydropyridin til brug i gelatine-bidekapsler.

Info

Publication number
DK130628B
DK130628B DK417572AA DK417572A DK130628B DK 130628 B DK130628 B DK 130628B DK 417572A A DK417572A A DK 417572AA DK 417572 A DK417572 A DK 417572A DK 130628 B DK130628 B DK 130628B
Authority
DK
Denmark
Prior art keywords
carbomethoxy
dihydropyridine
nitrophenyl
stabilizing
dimethyl
Prior art date
Application number
DK417572AA
Other languages
Danish (da)
English (en)
Other versions
DK130628C (ja
Inventor
F Bossert
W Vater
K Bauer
K-H Adams
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25761638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK130628(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE19722209526 external-priority patent/DE2209526C3/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK130628B publication Critical patent/DK130628B/da
Application granted granted Critical
Publication of DK130628C publication Critical patent/DK130628C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S206/00—Special receptacle or package
    • Y10S206/828—Medicinal content

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Hydrogenated Pyridines (AREA)
DK417572AA 1971-08-24 1972-08-23 Fremgangsmåde til stabilisering af en opløsning af 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-carbomethoxy-1,4-dihydropyridin til brug i gelatine-bidekapsler. DK130628B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2142316 1971-08-24
DE19722209526 DE2209526C3 (de) 1972-02-29 1972-02-29 Coronartherapeutlkum in Form von Gelatine-BeiBkapseln

Publications (2)

Publication Number Publication Date
DK130628B true DK130628B (da) 1975-03-17
DK130628C DK130628C (ja) 1975-08-25

Family

ID=25761638

Family Applications (1)

Application Number Title Priority Date Filing Date
DK417572AA DK130628B (da) 1971-08-24 1972-08-23 Fremgangsmåde til stabilisering af en opløsning af 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-carbomethoxy-1,4-dihydropyridin til brug i gelatine-bidekapsler.

Country Status (25)

Country Link
US (1) US3784684A (ja)
JP (2) JPS5434048B2 (ja)
KR (1) KR780000433B1 (ja)
BE (1) BE787951A (ja)
BG (1) BG27728A3 (ja)
CA (1) CA981582A (ja)
CY (1) CY918A (ja)
DD (1) DD99729A5 (ja)
DK (1) DK130628B (ja)
EG (1) EG10633A (ja)
ES (1) ES406047A1 (ja)
FI (1) FI53922C (ja)
FR (1) FR2150848B1 (ja)
GB (1) GB1362627A (ja)
HK (1) HK44877A (ja)
IE (1) IE36891B1 (ja)
IL (1) IL40165A (ja)
KE (1) KE2756A (ja)
LU (1) LU65929A1 (ja)
MY (1) MY7800003A (ja)
NL (1) NL176836C (ja)
NO (1) NO138167C (ja)
RO (1) RO88521B (ja)
SG (1) SG34877G (ja)
SU (1) SU432703A3 (ja)

Families Citing this family (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA725808B (en) * 1971-08-24 1973-05-30 Bayer Ag A coronary agent in special form and processes for its manufacture
SU432703A3 (ja) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
US4198391A (en) * 1973-07-20 1980-04-15 R. P. Scherer Ltd. Pharmaceutical compositions
GB1481411A (en) * 1973-07-20 1977-07-27 Scherer Ltd R Pharmaceutical compositions
AT366576B (de) * 1974-02-22 1982-04-26 Wellcome Found Verfahren zur herstellung von pharmazeutischen praeparaten
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
US4056610A (en) * 1975-04-09 1977-11-01 Minnesota Mining And Manufacturing Company Microcapsule insecticide composition
JPS52151724A (en) * 1976-06-07 1977-12-16 Takeda Chem Ind Ltd Hard shell gelatin capsule
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS5484023A (en) * 1977-12-19 1979-07-04 Teijin Ltd Soft capsule containing active vitamin d3, and its preparation
JPS5522645A (en) * 1978-08-07 1980-02-18 Fujisawa Pharmaceut Co Ltd Soft capsule for encapsulation of light-unstable compound
JPS5522631A (en) * 1978-08-07 1980-02-18 Ota Seiyaku Kk Readily absorbable nifedipine preparation
US5264446A (en) * 1980-09-09 1993-11-23 Bayer Aktiengesellschaft Solid medicament formulations containing nifedipine, and processes for their preparation
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
JPS5939827A (ja) * 1982-08-27 1984-03-05 Nitto Electric Ind Co Ltd 医療用外用部材
DE3307353C2 (de) * 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
DE3307422A1 (de) * 1983-03-03 1984-09-06 Bayer Ag, 5090 Leverkusen Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen
US4620974A (en) * 1983-07-07 1986-11-04 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4832952A (en) * 1983-07-07 1989-05-23 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
US4777048A (en) * 1983-07-07 1988-10-11 American Home Products Corporation Pharmaceutical composition containing a liquid lubricant
ATE33348T1 (de) * 1983-11-30 1988-04-15 Siegfried Ag Coronartherapeutikum in form von weichgelatinekapseln.
DE3419129A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Nifedipinpraeparate und verfahren zu ihrer herstellung
DE3419130A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung
US5266581A (en) * 1984-07-04 1993-11-30 Bayer Aktiengesellschaft Solid composition containing dihydropyridine, PVP and PVPP
EP0175671A1 (de) * 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
DE3438830A1 (de) * 1984-10-23 1986-04-30 Rentschler Arzneimittel Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung
DE3532129A1 (de) * 1985-09-10 1987-03-12 Bayer Ag Ss-carotin enthaltende gelatine
GB8522453D0 (en) * 1985-09-11 1985-10-16 Lilly Industries Ltd Chewable capsules
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
US4689233A (en) * 1986-01-06 1987-08-25 Siegfried Aktiengesellschaft Coronary therapeutic agent in the form of soft gelatin capsules
US4656028A (en) * 1986-06-24 1987-04-07 Norcliff Thayer Inc. Encapsulated antacid
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
DE3645036A1 (de) * 1986-11-18 1989-01-05 Forschungsgesellschaft Rauchen Nikotinhaltiges mittel
GB8629761D0 (en) * 1986-12-12 1987-01-21 Harris Pharma Ltd Capsules
EP0272336B1 (de) * 1986-12-18 1991-10-23 Kurt H. Prof. Dr. Bauer Gegenüber Lichteinfluss stabilisiertes Nifedipin-Konzentrat und Verfahren zu seiner Herstellung
DE3714402A1 (de) * 1987-04-30 1988-11-10 Kali Chemie Pharma Gmbh Arzneimittelformulierung
DE3738236A1 (de) * 1987-11-11 1989-05-24 Euro Celtique Sa Beisskapsel
US4954346A (en) * 1988-06-08 1990-09-04 Ciba-Geigy Corporation Orally administrable nifedipine solution in a solid light resistant dosage form
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
CA2056032A1 (en) * 1990-11-29 1992-05-30 Minoru Aoki Hard capsule preparation
US5431916A (en) * 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
US6726930B1 (en) * 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
AU2190697A (en) * 1996-04-12 1997-11-07 Flemington Pharmaceutical Corporation Buccal polar spray or capsule
WO1998001117A1 (en) 1996-07-08 1998-01-15 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
JP4730985B2 (ja) * 1997-09-10 2011-07-20 武田薬品工業株式会社 安定化された医薬製剤
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
ES2293875T3 (es) 1997-10-01 2008-04-01 Novadel Pharma Inc. Aerosol bucal no polar.
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20030077227A1 (en) 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US6056977A (en) * 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US20030102246A1 (en) * 1999-03-20 2003-06-05 Lts Lohmann Therapie-Systeme Ag Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof
ES2350822T3 (es) * 1999-08-31 2011-01-27 Chugai Seiyaku Kabushiki Kaisha Cápsulas blandas.
IL143375A0 (en) * 1999-09-30 2002-04-21 Penwest Pharmaceuticals Co Sustained release matrix systems for highly soluble drugs
WO2002087543A1 (en) * 2001-05-01 2002-11-07 Biozone Laboratories, Inc. Sustained release formulations for nifedipine, dextromethorphan, and danazol
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
CN102600104B (zh) 2002-04-25 2015-06-24 旗帜药物胶囊公司 可咀嚼的软胶囊
WO2003094897A1 (fr) * 2002-05-09 2003-11-20 Chugai Seiyaku Kabushiki Kaisha Capsule souple photostabilisee
PT1944029E (pt) * 2005-10-31 2012-02-09 Nissan Chemical Ind Ltd Preparação farmacêutica com excelente fotoestabilidade
CA2649895C (en) * 2006-04-19 2013-03-26 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
US20080171089A1 (en) * 2006-12-22 2008-07-17 Blondino Frank E Stable anti-nausea oral spray formulations and methods
BRPI0811430A2 (pt) * 2007-05-10 2015-06-23 Novadel Pharma Inc Composições anti-insônia e processos
US7985325B2 (en) * 2007-10-30 2011-07-26 Novellus Systems, Inc. Closed contact electroplating cup assembly
JP2011510005A (ja) * 2008-01-18 2011-03-31 ダウ グローバル テクノロジーズ インコーポレイティド メトキシポリエチレングリコールを用いる難溶性活性物質の水溶解度増強方法
CN106344533A (zh) * 2009-01-29 2017-01-25 大日本住友制药株式会社 具有内核的口腔崩解片剂
CN102160872A (zh) 2010-02-23 2011-08-24 天津天士力制药股份有限公司 复方丹参滴丸胶囊
TWI571257B (zh) * 2011-02-23 2017-02-21 Tasly Pharmaceutical Group Co Capsule preparation
CA3100248A1 (en) * 2018-05-14 2019-11-21 Capsugel Belgium Nv Capsules with opacifier
CN112955965B (zh) 2018-06-14 2024-04-09 阿斯利康(英国)有限公司 使用二氢吡啶类钙通道阻断剂医药组合物降低血压的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870061A (en) * 1956-11-08 1959-01-20 Mead Johnson & Co Concentrates of dialkyl sulfosuccinates
US3155587A (en) * 1963-01-23 1964-11-03 American Cyanamid Co Stable liquid preparations of 7-chlorotetracycline
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
SU432703A3 (ja) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер

Also Published As

Publication number Publication date
FR2150848A1 (ja) 1973-04-13
BE787951A (fr) 1973-02-26
JPS5434048B2 (ja) 1979-10-24
CY918A (en) 1977-12-23
IE36891B1 (en) 1977-03-16
LU65929A1 (ja) 1973-01-15
IL40165A0 (en) 1972-10-29
NO138167C (no) 1978-07-26
GB1362627A (en) 1974-08-07
RO88521B (ro) 1987-05-01
CA981582A (en) 1976-01-13
JPS53121921A (en) 1978-10-24
KE2756A (en) 1977-10-14
FR2150848B1 (ja) 1976-04-16
EG10633A (en) 1976-08-31
KR780000433B1 (en) 1978-10-14
IE36891L (en) 1973-02-24
NL7211565A (ja) 1973-02-27
NO138167B (no) 1978-04-10
ES406047A1 (es) 1981-08-16
BG27728A3 (en) 1979-12-12
NL176836C (nl) 1985-06-17
DK130628C (ja) 1975-08-25
US3784684A (en) 1974-01-08
MY7800003A (en) 1978-12-31
NL176836B (nl) 1985-01-16
FI53922C (fi) 1979-09-07
HK44877A (en) 1977-09-09
IL40165A (en) 1975-03-13
DD99729A5 (ja) 1973-08-20
RO88521A (ro) 1987-04-30
JPS4828621A (ja) 1973-04-16
SU432703A3 (ja) 1974-06-15
FI53922B (fi) 1978-05-31
SG34877G (en) 1987-04-03

Similar Documents

Publication Publication Date Title
DK130628B (da) Fremgangsmåde til stabilisering af en opløsning af 4-(2'-nitrophenyl)-2,6-dimethyl-3,5-carbomethoxy-1,4-dihydropyridin til brug i gelatine-bidekapsler.
BG20353A3 (bg) Метод за получаване на несиметрични 1,4-дихидропиридини
SE434049B (sv) Forfarande for framstellning av 1,4-dihydropyridinderivat
AT306720B (de) Verfahren zur Herstellung von neuen 1,4-Dihydropyridinderivaten
AT302302B (de) Verfahren zur Herstellung von neuen 1,4-Dihydropyridinderivaten
AT301546B (de) Verfahren zur Herstellung von neuen 1,4-Dihydropyridinderivaten
AT293389B (de) Verfahren zur Herstellung von neuen 1,4-Dihydropyridin-Derivaten
DK140098B (da) Analogifremgangsmåde til fremstilling af 2-((substitueret piperidinyl eller tetrahydropyridinyl)alkyl)-1H-benz(de)-isoquinolin-1,3(2H)-dioner eller syreadditionssalte deraf.
SE425660B (sv) Analogiforfarande for framstellning av 1,4-dihydropyridiner
DK138893B (da) Analogifremgangsmåde til fremstilling af 1-(indolyl-3-alkyl)-4-ureido-piperidiner eller -thioureido-piperidiner eller syreadditionssalte deraf.
IT1063091B (it) Mescolanze di copoliesteri,copolimeri etilene-acido carbossilico e una policarbodiimide
DK103184C (da) Fremgangsmåde til fremstilling af 3-(3'-dimetylaminopropyliden)-dibenzo (a,d) cyclohepta-1,4-dien-N-oxyd eller syreadditionssalte heraf.
CH557820A (de) Verfahren zur herstellung von neuen 2-(2-hydroxyalkyl)4,5-dihydro-pyridazin (2h)-3-onen.
DK142578C (da) Analogifremgangsmaade til fremstilling af 2,4-diamino-5-benzylpyrimidiner og syreadditionssalte deraf
BE848909A (fr) Nouvelles isothiourees, procede pour les preparer et compositions pharmaceutiques les contenant
DK138497B (da) Analogifremgangsmåde til fremstilling af 4-hydroxy-4-(3,4-methylen-dioxyphenyl)piperidiner eller salte deraf.
DK142992C (da) Fremgangsmaade til fremstilling af steroid-17-spirolactoner eller metalsalte af den tilsvarende hydroxycarboxylsyre af den 6,7-umaettede forbindelse
DK138642B (da) Fremgangsmåde til fremstilling af stereoisomere af 1-(1'-(o-chlorbenzyl)-2'-pyrryl)-2-disek.-butylaminoethanol eller salte deraf.
DK214076A (da) 3,5-bisoxygenerede 2-(omega-halogen-3-oxygeneret-1-alkenyl)-cyclopentan-1-heptansyrer og derivater deraf fremgangsmade til til fremstilling deraf
DK129237B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolinderivater og salte deraf.
SE7613536L (sv) Sett att framstella 3,4-disubstituerade 2-(beta-naftyl-oxi)-etylpyrazoloner och anvendning derav som lekemedel
AT319248B (de) Verfahren zur Herstellung von neuen 1,4-Dihydro-3(2H)-isochinolinon-Derivaten und deren Salzen
DK124685B (da) Fremgangsmåde til fremstilling af 1-[(2'-alkyl-4'-aminopyrimidyl-5')-metyl]-pyridiniumderivater.
BG20348A3 (bg) Метод за получаване на 4-субституирани 1-(4,4-диарил-бутил) пиперидини
DK132082B (da) Analogifremgangsmåde til fremstilling af bis(4-/1-(quinazolinyl-4)piperidyl/)alkaner.

Legal Events

Date Code Title Description
PUP Patent expired